RESONIUM 999.34mg / g powder for oral/rectal suspension medication leaflet

V03AE01 sodium polystyrene sulfonate • Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Sodium polystyrene sulfonate is a medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood. It is prescribed to lower potassium levels, thereby preventing serious complications such as cardiac arrhythmias.

It works through ion exchange: sodium from the medication is released in the intestine, while potassium is bound and excreted in the stool. It is available as a powder or oral suspension and, in some cases, can be administered rectally.

While effective, sodium polystyrene sulfonate may cause side effects such as constipation, nausea, vomiting, or, more rarely, electrolyte imbalances like hyponatremia or hypocalcemia. In rare cases, intestinal ischemia or necrosis may occur, particularly in patients with pre-existing gastrointestinal conditions.

Patients should strictly follow their doctor’s instructions and inform their healthcare provider about other medications they are taking, as sodium polystyrene sulfonate can interact with certain treatments, potentially affecting their efficacy.

General data about RESONIUM 999.34mg / g

Substance: sodium polystyrene sulfonate

Date of last drug list: 01-12-2025

Commercial code: W70787001

Concentration: 999.34mg / g

Pharmaceutical form: powder for oral/rectal suspension

Quantity: 1

Product type: generic

Prescription restrictions: X

Marketing authorisation

Manufacturer: SANOFI AVENTIS ZRT - UNGARIA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 1003/2024/01

Shelf life: 4 years